Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease

被引：0
|
作者：
Patoulias, Dimitrios [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Gen Hosp Hippokration, Dept Cardiol 2, Thessaloniki, Greece
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 07期
关键词：
D O I：
10.7326/L23-0069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dapagliflozin: reduced diabetes incidence in chronic kidney disease? Comments
    Schwarz, Peter
    DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (02) : 113 - 114
  • [42] Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial
    Akihiko Koshino
    Brendon L. Neuen
    Niels Jongs
    Carol Pollock
    Peter J. Greasley
    Eva-Marie Andersson
    Ann Hammarstedt
    Cecilia Karlsson
    Anna Maria Langkilde
    Takashi Wada
    Hiddo J.L. Heerspink
    Cardiovascular Diabetology, 22
  • [43] Effects of Statins in Patients with Chronic Kidney Disease
    Ge, L.
    CARDIOLOGY, 2009, 114 : 139 - 140
  • [44] Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial
    Koshino, Akihiko
    Neuen, Brendon L.
    Jongs, Niels
    Pollock, Carol
    Greasley, Peter J.
    Andersson, Eva-Marie
    Hammarstedt, Ann
    Karlsson, Cecilia
    Langkilde, Anna Maria
    Wada, Takashi
    Heerspink, Hiddo J. L.
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [45] Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages
    Lin, Yi-Hsuan
    Huang, Yu-Yao
    Hsieh, Sheng-Hwu
    Sun, Jui-Hung
    Chen, Szu-Tah
    Lin, Chia-Hung
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [46] The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis
    McEwan, Phil
    Gabb, Peter D.
    Davis, Jason A.
    Sanchez, Juan Jose Garcia
    Sjostrom, C. David
    Barone, Salvatore
    Kashioulis, Pavlos
    Ouwens, Mario
    Cassimaty, Syd
    Correa-Rotter, Ricardo
    Rossing, Peter
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (12) : 2040 - 2047
  • [47] Use of dapagliflozin in patients with advanced diabetic kidney disease
    Park, Hyun Sun
    Jung, Youn Joo
    Lee, Dong-Young
    Moon, Kyoung Hyoub
    Kim, Beom
    Kim, Hae Won
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2018, 37 (03) : 292 - 297
  • [48] THE RELATIONSHIP BETWEEN SEVERITY OF CHRONIC KIDNEY DISEASE AND HOSPITALIZATIONS IN PATIENTS WITH TYPE 2 DIABETES
    Lage, M. J.
    Boye, K. S.
    Paczkowski, R.
    Curtis, B.
    VALUE IN HEALTH, 2013, 16 (03) : A155 - A155
  • [49] Evaluation of the Pharmacokinetics of Dapagliflozin in Patients With Chronic Kidney Disease With or Without Type 2 Diabetes Mellitus
    Penland, Robert C.
    Melin, Johanna
    Boulton, David W.
    Tang, Weifeng
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (05): : 551 - 559
  • [50] The Authors' Reply to "How to Demonstrate the Impact of Dapagliflozin on Improving Hyperuricemia in Patients with Chronic Kidney Disease"
    Mori, Daisuke
    Kobayashi, Midori
    Wada, Masafumi
    Tokuchi, Maho
    Misegawa, Soichiro
    Saito, Rina
    Nomi, Hiroki
    Haga, Ryota
    Nagatoya, Katsuyuki
    Yamauchi, Atsushi
    INTERNAL MEDICINE, 2024, 63 (15) : 2229 - 2230
12345